Wilson, NCNCT06087653Now EnrollingIRB Ready

Multiple Myeloma Clinical Trial in Wilson, NC

Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Wilson. Study-provided care at no cost to qualified participants.

Sponsored by Starton Therapeutics, Inc

Quick Self-Assessment

See if you qualify for this Wilson location

Preparing your pre-screening questions...

Expert Care in Wilson

Access multiple myeloma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple myeloma treatment provided free

Apply for This Wilson Location

Check if you qualify for this multiple myeloma clinical trial in Wilson, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Wilson

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Wilson site if eligible
  4. 4Begin participation

About This Multiple Myeloma Study in Wilson

Primary Objective • Assess the safety and tolerability of low-dose lenalidomide administered by continuous subcutaneous (SC) infusion (STAR-LLD) in combination with dexamethasone and a proteasome inhibitor (PI). Secondary Objectives * • To establish the pharmacokinetic (PK) profile of STAR-LLD at a defined infusion rate targeting steady-state blood concentrations. * • Evaluate changes in efficacy indicators including objective response rate (ORR), progression-free survival (PFS), and duration

Sponsor: Starton Therapeutics, Inc

Who Can Participate

Inclusion Criteria

Male or female ≥18 years at the time of informed consent. 2. Autologous stem cell transplant (ASCT) ineligible. 3. SARS -CoV2 virus (COVID)-19 negative. 4. A prior diagnosis of MM as defined by International Myeloma Working Group (IMWG) criteria (Appendix 7). 5. Documented measurable disease following first line therapy defined as:
Serum monoclonal protein ≥1.0 g/dL by protein electrophoresis.
≥200 mg/24 hours of monoclonal protein in the urine on 24-hour electrophoresis.
Serum free light chain (SFLC) ≥10 mg/dL AND abnormal serum kappa to lambda free light chain (FLC) ratio. 6. Intended to be treated in 2nd line or greater with lenalidomide, dexamethasone, and a PI. 7. Proteasome inhibitor sensitive defined as progression free for \> 6 months from cessation of PI or never received a prior PI. 8. Progression per IMWG criteria on the most recent line of therapy. 9. Eastern Cooperative Oncology Group (ECOG-Appendix 1) performance status ≤2 (patients

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Wilson?

Yes, this clinical trial (NCT06087653) has an active research site in Wilson, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Myeloma Treatment Options in Wilson, NC

If you're searching for multiple myeloma treatment options in Wilson, NC, this clinical trial (NCT06087653) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Wilson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple myeloma clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Wilson, NC

See all multiple myeloma clinical trials recruiting in Wilson — not just this study.

Browse Multiple Myeloma Trials in Wilson

Browse More Trials by Condition

Ready to Join in Wilson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Wilson, NC